Literature DB >> 21526486

The significance of Survivin and Nectin-4 expression in the prognosis of breast carcinoma.

Anna Maria Athanassiadou1, Efstratios Patsouris, Angelos Tsipis, Maria Gonidi, Pauline Athanassiadou.   

Abstract

To investigate the prognostic significance of Survivin and Nectin-4 expression in breast carcinomas. Imprint smears were obtained from 140 breast carcinoma specimens and studied immunocytochemically for the expression of Survivin and Nectin-4. The results were correlated with several clinicopathological parameters, including five-year survival. Increased Survivin staining pattern correlated with increased grade (p < 0.0001), increased lymph node invasion (p < 0.0001), increased tumor size and reduced survival (p < 0.0001). Elevated Nectin-4 expression also correlated significantly with increased grade (p < 0.0001), increased tumor size (p < 0.0001) and reduced survival (p < 0.0001). In addition, Survivin and Nectin-4 staining patterns correlated strongly with one another (p < 0.0001). However, on multivariate analysis, neither Survivin nor Nectin-4 expression seemed to have an independent impact on survival in our study cases. The findings of our study suggest that increased expression of Survivin and Nectin-4 may indicate a worse prognosis in breast cancer patients. The exact implications of the expression of these markers in breast cancer prognosis and treatment remain to be clarified.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21526486     DOI: 10.5603/fhc.2011.0005

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  28 in total

1.  Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: a meta-analysis.

Authors:  Shunzeng Lv; Ekaterina Turlova; Shigang Zhao; Huihui Kang; Mingzhi Han; Hong-Shuo Sun
Journal:  Tumour Biol       Date:  2013-10-08

Review 2.  Prognostic value of survivin expression in breast cancer patients: a meta-analysis.

Authors:  Jian Song; Hong Su; Yang-Yang Zhou; Liang-Liang Guo
Journal:  Tumour Biol       Date:  2013-05-21

3.  Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse.

Authors:  Chinmayee Sethy; Kunal Goutam; Deepika Nayak; Rajalaxmi Pradhan; Sefinew Molla; Subhajit Chatterjee; Niranjan Rout; Michael D Wyatt; Satya Narayan; Chanakya Nath Kundu
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-15       Impact factor: 4.553

4.  Construction of a rationally designed antibody platform for sequencing-assisted selection.

Authors:  H Benjamin Larman; George Jing Xu; Natalya N Pavlova; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-11       Impact factor: 11.205

5.  A Novel Nectin-mediated Cell Adhesion Apparatus That Is Implicated in Prolactin Receptor Signaling for Mammary Gland Development.

Authors:  Midori Kitayama; Kiyohito Mizutani; Masahiro Maruoka; Kenji Mandai; Shotaro Sakakibara; Yuki Ueda; Takahide Komori; Yohei Shimono; Yoshimi Takai
Journal:  J Biol Chem       Date:  2016-01-12       Impact factor: 5.157

6.  Serum nectin-2 and nectin-4 are diagnostic in lung cancer: which is superior?

Authors:  Kayhan Erturk; Sule Karaman; Nergiz Dagoglu; Murat Serilmez; Derya Duranyildiz; Faruk Tas
Journal:  Wien Klin Wochenschr       Date:  2019-08-22       Impact factor: 1.704

7.  SURVIVIN as a marker for quiescent-breast cancer stem cells-An intermediate, adherent, pre-requisite phase of breast cancer metastasis.

Authors:  Sumit Siddharth; Sarita Das; Anmada Nayak; Chanakya Nath Kundu
Journal:  Clin Exp Metastasis       Date:  2016-07-13       Impact factor: 5.150

Review 8.  Association of survivin splice variants with prognosis and treatment of breast cancer.

Authors:  Anastasia Pavlidou; Christos Kroupis; Kleanthi Dimas
Journal:  World J Clin Oncol       Date:  2014-12-10

9.  Expression of survivin does not appear to influence breast cancer recurrence risk.

Authors:  Lindsay J Collin; Deirdre P Cronin-Fenton; Thomas P Ahern; Kristina B Christensen; Per Damkier; Stephen Hamilton-Dutoit; Anders Kjaersgaard; Kristina L Lauridsen; Rami Yacoub; Peer Christiansen; Henrik Toft Sørensen; Timothy L Lash
Journal:  Acta Oncol       Date:  2018-10-23       Impact factor: 4.089

10.  Preclinical Evaluation of an Anti-Nectin-4 ImmunoPET Reagent in Tumor-Bearing Mice and Biodistribution Studies in Cynomolgus Monkeys.

Authors:  Dean O Campbell; Akihiro Noda; Alla Verlinsky; Josh Snyder; Yuji Fujita; Yoshihiro Murakami; Hiroshi Fushiki; Sosuke Miyoshi; Sergio Lacayo; Edward Cabral; Peng Yang; David R Stover; Ingrid B J K Joseph
Journal:  Mol Imaging Biol       Date:  2016-10       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.